A Comparative Effectiveness Study of Major Glycemia-lowering Medications for Treatment of Type 2 Diabetes (GRADE)

This study is currently recruiting participants. (see Contacts and Locations)

Verified August 2016 by GRADE Study Group

Sponsor:

Collaborators:

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

National Heart, Lung, and Blood Institute (NHLBI)

Becton, Dickinson and Company

Bristol-Myers Squibb

Merck Sharp & Dohme Corp.

Novo Nordisk A/S

Hoffmann-La Roche

Sanofi

Information provided by (Responsible Party):

GRADE Study Group

ClinicalTrials.gov Identifier:

NCT01794143

First received: February 13, 2013

Last updated: August 26, 2016

Last verified: August 2016

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study is currently recruiting participants.
Estimated Study Completion Date:	No date given
Estimated Primary Completion Date:	August 2020 (Final data collection date for primary outcome measure)